» Authors » R J Shulman

R J Shulman

Explore the profile of R J Shulman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 1040
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamp K, Plantinga A, Cain K, Burr R, Tsai C, Wu Q, et al.
Benef Microbes . 2024 May; 15(3):259-273. PMID: 38821492
Irritable bowel syndrome (IBS), a disorder of gut-brain interaction, is associated with abdominal pain and stool frequency/character alterations that are linked to changes in microbiome composition. We tested whether taxa...
2.
Heitkemper M, Cain K, Shulman R, Burr R, Ko C, Hollister E, et al.
Benef Microbes . 2018 Apr; 9(3):345-355. PMID: 29633639
Previously we showed that urine trefoil factor 3 (TFF3) levels were higher in females with irritable bowel syndrome (IBS) compared to non-IBS females. To assess if TFF3 is associated with...
3.
Chumpitazi B, Kearns G, Shulman R
Aliment Pharmacol Ther . 2018 Jan; 47(6):738-752. PMID: 29372567
Background: Peppermint oil has been used for centuries as a treatment for gastrointestinal ailments. It has been shown to have several effects on gastrointestinal physiology relevant to clinical care and...
4.
Jarrett M, Han C, Cain K, Burr R, Shulman R, Barney P, et al.
Neurogastroenterol Motil . 2016 Mar; 28(7):1094-103. PMID: 26993039
Background: Irritable bowel syndrome (IBS) is a heterogeneous condition with a number of pathophysiological mechanisms that appear to contribute to symptom chronicity. One of these is altered pain sensitivity. Methods:...
5.
Chumpitazi B, Self M, Czyzewski D, Cejka S, Swank P, Shulman R
Neurogastroenterol Motil . 2015 Dec; 28(3):443-8. PMID: 26690980
Background: Rater reproducibility of the Bristol Stool Form Scale (BSFS), which categorizes stools into one of seven types, is unknown. We sought to determine reliability and agreement by individual stool...
6.
Chumpitazi B, Shulman R
Aliment Pharmacol Ther . 2015 Oct; 42(11-12):1330. PMID: 26510543
No abstract available.
7.
Chumpitazi B, Shulman R
Aliment Pharmacol Ther . 2015 Aug; 42(6):776. PMID: 26278562
No abstract available.
8.
Chumpitazi B, Cope J, Hollister E, Tsai C, McMeans A, Luna R, et al.
Aliment Pharmacol Ther . 2015 Jun; 42(4):418-27. PMID: 26104013
Background: A low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet can ameliorate symptoms in adult irritable bowel syndrome (IBS) within 48 h. Aim: To determine the efficacy of a...
9.
Self M, Williams A, Czyzewski D, Weidler E, Shulman R
Neurogastroenterol Motil . 2015 May; 27(8):1110-9. PMID: 26017930
Background: In functional gastrointestinal disorders, patient recall of symptoms drives diagnostic decisions and evaluation of treatment response, and research conclusions about potential treatments. In pediatrics, parent report also impacts assessment...
10.
Wong G, Shulman R, Chumpitazi B
Neurogastroenterol Motil . 2015 Jan; 27(3):356-62. PMID: 25557417
Background: A standardized 4-h adult-based gastric emptying scintigraphy (GES) protocol is increasingly being used in children to evaluate for gastroparesis. We sought to determine the effect of age, anthropometrics, and...